References
- Stimpson N, Agravad N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatr 2002;181:284–94.
- Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry 2001;62 Suppl 16:18–25.
- Nierenberg AA, Papakostas GI, Petersen T, Kelly KE, Iacoviello BM, Worthington JJ, et al. Nortriptyline for treatment-resistant depression. J Clin Psychiatry 2003;64:35–9.
- Bech P. Pharmacological treatment of depressive disorders: A review. In: Maj M, Sartorius N, editors. Depressive disorders. WPA Series Evidence and Experience in Psychiatry. Chichester: John Wiley & Sons; 1999. p. 89–127.
- Bech P. Rating scales for affective disorders: Their validity and consistency. Acta Psychiatr Scand 1981;64 Suppl 295:1–101.
- Blom-Peters L, Lamy M. Monoamine oxidase inhibitors and anaesthesia: An updated literature review Acta Anaesth Belg 1993; 44:57–60.
- Paykel ES. Epidemiology of Refractory Depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD, editors. Refractory depression. Current strategies and future directions. Chichester: John Wiley & Sons; 1994. p. 3–18.
- Wharton RN, Perel JM, Dayton PG, Malitz S. A potential clinical use for methylphendiate with tricyclic antidepressants. Am J Psychiatry 1971;127:55–61.
- Fawcett J, Busch KA. Stimulants in psychiatry. In: Schatzberg AF, Nemeroff CB, editors. Essentials of clinical psychopharmacology. Washington DC: American Psychiatry Association; 2001. p. 303–28.
- Chapotot F, Pigeau R, Canini F, Bourdon L, Buguet A. Distinctive effects of modafinil and a-amphetamine on the homeostatic and circadian modulation of human waking EEG. Psychopharmacol-ogy 2003;166:127–38.
- Robertson P, Hellriegel ET. Clinical pharmacokinetic profile of modafinil. Clin Pharmacokinet 2003;42:123–37.
- Menza MA, Kaufmann KR, Castellanous AM. Modafinil aug-mentation of antidepresant treatment in depression. J Clin Psychiatry 2000;61:378–81.
- Markovitz PJ, Wagner S. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy. J Clin Psychopharmacol 2003;23:207–9.
- Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: A step in the validation of a new self-report scale. Br J Psychiatry 1976;128: 280–9.
- Bech P, Rasmussen N-A, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001;66:159–64.
- Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major depression Inventory in measuring severity of depressive states. Psychol Med 2003;33:351–6.
- Thunedborg K, Allerup P, Bech P, Joyse CRB. Development of the repertory grid for measurement of individual quality of life in clinical trials. Int J Meth Psychiatr Res 1993;3:48–58.
- Olsen LR, Mortensen EL, Bech P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand 2004;110: 225–9.
- Olsen LR, Mortensen EL, Bech P. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand 2004;109:96–103.